Table II.
Epidermal growth factor receptor (EGFR) and p53 with pathological classifications and clinical stages.
EGFR | p53 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||
0 | 1+ | 2+ | 3+ | Statistical value | 0 | 1+ | 2+ | 3+ | Statistical value | |
Pathological classification | p<0.001 r=0.515 |
p<0.001 r=0.471 |
||||||||
A | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | ||
AB | 3 | 2 | 0 | 0 | 2 | 2 | 1 | 0 | ||
B1 | 2 | 2 | 3 | 0 | 1 | 6 | 0 | 0 | ||
B2 | 6 | 2 | 3 | 3 | 2 | 4 | 5 | 3 | ||
B3 | 1 | 1 | 5 | 4 | 1 | 4 | 3 | 3 | ||
C | 0 | 1 | 1 | 2 | 0 | 1 | 1 | 2 | ||
Total | 13 | 9 | 12 | 9 | 7 | 18 | 10 | 8 | ||
Clinical stage | p=0.003 r=0.443 |
p=0.289 N/A |
||||||||
I | 6 | 4 | 0 | 1 | 1 | 6 | 4 | 0 | ||
II | 6 | 5 | 9 | 5 | 6 | 9 | 4 | 6 | ||
III | 1 | 0 | 1 | 2 | 0 | 2 | 2 | 0 | ||
IV | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 2 | ||
Total | 13 | 9 | 12 | 9 | 7 | 18 | 10 | 8 |